OPKO Health to Present at 2008 Wachovia Healthcare Conference
MIAMI, Jan. 23 /PRNewswire-FirstCall/ -- OPKO Health, Inc. (Amex: OPK) today announced that it will present at the 2008 Wachovia Healthcare Conference on Wednesday, January 30, 2008 at 11:15 am EST. The conference will be held at the Langham Hotel in Boston.
OPKO senior management will provide a review of recent corporate developments.
A live audio webcast and replay of the company's presentation will be available at the Investor Relations section of the company's website at www.opko.com.
About OPKO Health, Inc.
Miami-based OPKO is a specialty healthcare company. Its lead investigational drug, the pioneering gene silencing agent bevasiranib, has entered a pivotal Phase III trial after successfully completing Phase II trials for wet age-related macular degeneration and diabetic macular edema. OPKO is developing a pipeline of novel agents for ophthalmic diseases, and it markets innovative diagnostic imaging systems that complement the company's therapeutic products. For more information visit the company's website at www.opko.com.
Contacts: Media: Corporate: GendeLLindheim BioCom Partners Steven D. Rubin Barbara Lindheim 305 575-6000 212 918-4650
SOURCE OPKO Health, Inc.
Released January 23, 2008